Goldman Sachs’s Conformis, Inc. Common Stock CFMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-994
Closed -$15K 6888
2022
Q1
$15K Sell
994
-32
-3% -$526 ﹤0.01% 6448
2021
Q4
$20K Sell
1,026
-3,071
-75% -$78.7K ﹤0.01% 6370
2021
Q3
$136K Sell
4,097
-1,933
-32% -$68.1K ﹤0.01% 5846
2021
Q2
$173K Buy
6,030
+2,119
+54% +$50K ﹤0.01% 5794
2021
Q1
$97K Buy
3,911
+2,865
+274% +$77.3K ﹤0.01% 5855
2020
Q4
$17K Sell
1,046
-159
-13% -$2.74K ﹤0.01% 5441
2020
Q3
$25K Sell
1,205
-2,776
-70% -$53K ﹤0.01% 5242
2020
Q2
$82K Buy
3,981
+1,453
+57% +$30.4K ﹤0.01% 5016
2020
Q1
$40K Sell
2,528
-243
-9% -$5.94K ﹤0.01% 5075
2019
Q4
$104K Buy
2,771
+2,005
+262% +$95.1K ﹤0.01% 5040
2019
Q3
$36K Sell
766
-523
-41% -$31.4K ﹤0.01% 5074
2019
Q2
$140K Sell
1,289
-2,211
-63% -$182K ﹤0.01% 4874
2019
Q1
$252K Buy
3,500
+1,744
+99% +$49.7K ﹤0.01% 4704
2018
Q4
$16K Sell
1,756
-89
-5% -$1.5K ﹤0.01% 5163
2018
Q3
$49K Sell
1,845
-5,971
-76% -$162K ﹤0.01% 5295
2018
Q2
$244K Buy
7,816
+359
+5% +$12.4K ﹤0.01% 4899
2018
Q1
$270K Buy
7,457
+2,082
+39% +$87.4K ﹤0.01% 4838
2017
Q4
$319K Buy
5,375
+22
+0.4% +$1.76K ﹤0.01% 5144
2017
Q3
$471K Sell
5,353
-445
-8% -$44.1K ﹤0.01% 5135
2017
Q2
$622K Sell
5,798
-128
-2% -$15.4K ﹤0.01% 4899
2017
Q1
$773K Buy
5,926
+5,507
+1,314% +$932K ﹤0.01% 4620
2016
Q4
$85K Sell
419
-81
-16% -$17.9K ﹤0.01% 6213
2016
Q3
$124K Buy
500
+91
+22% +$18.3K ﹤0.01% 6121
2016
Q2
$72K Sell
409
-501
-55% -$118K ﹤0.01% 6278
2016
Q1
$245K Sell
910
-141
-13% -$37.3K ﹤0.01% 5435
2015
Q4
$454K Sell
1,051
-2,671
-72% -$1.34M ﹤0.01% 5009
2015
Q3
$1.68M Buy
+3,722
New +$1.87M ﹤0.01% 3973

Other funds holding CFMS

Goldman Sachs's CFMS Position: Q2 2022 in Review

Goldman Sachs sold out of Conformis, Inc. Common Stock (CFMS) in Q2 2022, closing a stake of 994 shares — an estimated $15K sold.

Goldman Sachs first reported a position in CFMS in Q3 2015 and held it in 27 quarters. The position peaked at $1.68M in Q3 2015. 81 funds tracked by Wall St. Rank hold CFMS as of Q2 2022.

  • Goldman Sachs reported no remaining Conformis, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Goldman Sachs sold 994 Conformis, Inc. Common Stock shares in Q2 2022, an estimated $15K.
  • Goldman Sachs first reported a position in Conformis, Inc. Common Stock in Q3 2015 and held it in 27 quarters.
  • Goldman Sachs's Conformis, Inc. Common Stock position peaked at $1.68M in Q3 2015.
  • 81 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q2 2022.

Based on Goldman Sachs's 13F filing for Q2 2022, filed 15 Aug 2022.